期刊文献+

慢性ITP小鼠外周血IL-11及其受体水平的研究 被引量:1

IL-11 and IL-11 receptor levels in the blood of mice with chronic idiopathic thrombocytopenic purpura
原文传递
导出
摘要 目的测定慢性特发性血小板减少性紫癜(CITP)小鼠外周血中IL-11及其受体(IL-11R)的水平,探讨CITP的发病机制,为ITP的治疗提供新的理论依据。方法BALA/C小鼠60只,随机分为对照组(20只)和CITP组(40只),通过腹腔注射豚鼠抗小鼠血小板血清(APS)的方法建立CITP模型。于造模第8d分别采用ELISA、流式细胞术测定两组小鼠外周血中IL-11及IL-11R的水平。结果CITP小鼠外周血中IL-11及IL-11R平均水平均较对照组升高(P<0.05);其中有31只小鼠同时存在IL-11及IL-11R水平的升高,余9只小鼠仅存在IL-11水平的升高,而IL-11R水平降低。结论IL-11及IL-11R在CITP的发病机制中起一定作用,但它们发挥作用的原理及过程尚需进一步探讨。 Objective To explore IL- 11 and IL- 11 receptor in the blood of mice with chronic idiopathic thrombocytopenic purpura (CITP) and to assess whether the absence of IL-11 or the IL-11 receptor will provide a new theory in the treatment of CITP. Methods 60 BALB/C mice which were randomly divided into two groups (20 mice in the control group and 40 in the C/TP group). The model of CITP was induced using intra-peritoneal APS injection. Levels of IL-11 and IL-11 receptors were deter- mined using ELISA and flowcytometry at the 8th day. Results The levels of IL-11 and the IL-11 receptor in the blood of group CITP were higher thatthose of group control ( P 〈0.05). In 31 mice of the CITP group,both the level of IL-11 and of the IL-11 receptor in the blood were increased, while in the remaining 9 mice of the CITP group,the level of IL-11 in the blood was increased but the level of the IL- 11 receptor was decreased. Conclusion IL-11 may have a certain action in the mechanism of ITP.
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第4期69-71,共3页 Journal of Shandong University:Health Sciences
关键词 白细胞介素11 受体 白细胞介素11 紫癜 血小板减少性 特发性 Interleukin 11 IL-11 receptor Chronic idiopathic thrombocytopenic purpura
  • 相关文献

参考文献12

  • 1杨宇飞,周霭祥,麻柔.免疫性血小板减少性紫癜动物模型的建立[J].中华血液学杂志,1994,15(3):160-161. 被引量:86
  • 2杨宇飞.免疫性血小板减少性紫癜实验动物模型研究进展[J].中国中医基础医学杂志,1995,1(3):43-45. 被引量:9
  • 3Zhou B, Zhao H, Yang R C, et al. Multi-dysfunctional pathophysiology in 1TP[JJ. Crit Rev Oncol Hematol, 2005, 54(6) : 107.
  • 4Ogawara H, Handa H, Morita K, et al. High Thl/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura[ J]. Eur J Haematol, 2003, 71(8) :283.
  • 5Blanchette V. Childhood chronic immune thrombocytopenic purpura[J]. Blood Rev, 2002, 16(1) :23.
  • 6Goldman S C, Bracho F, Davenport V, et al. Fensibility of IL- 11 and granulovyte colony-stimulating factor after myelosuppresive chemotherapy to molilize peripheral blood stem cells from heavily pretreated patients[J]. J Pediatr Hematol, 2001, 23 (5) :300-305.
  • 7Curti A, Tafuri A, Taski K, et al. Interleukin-11 induces proliferation of human-T-cells and its activity is associated with downregulation of p27 ( kipl ) [ J ]. Haematologica, 2002, 87 (4) : 373-380.
  • 8Reynold C H. Clinical efficacy of rhll-11 [J]. Oncology, 2000, 14(9) :32.
  • 9Chen Q, Rabach L, Noble P, et al. IL-11 receptor alpha in the pathogenesis of IL-13-induced in flammation and remodeling[J]. Immunology, 2005, 174(4):2305-13.
  • 10Chang M, Suen Y. Disserential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production[J]. Blood, 1996, 88(9):3354-3362.

二级参考文献9

  • 1杨宇飞,周霭祥,麻柔.免疫性血小板减少性紫癜动物模型的建立[J].中华血液学杂志,1994,15(3):160-161. 被引量:86
  • 2Du X,Williams DA.Interleukin-11:review of molecular,cell biology and clinical use.Blood,1997; 89:3897 - 3908
  • 3Nakajima A,Hirone S,Yagita H,et al.Role of IL-4 and IL-12 in the development of lupus in NIB/WF1 mice.J Immunol,1997; 158:1466 - 1472
  • 4Kaushansky K.Use of thrombopoietic growth factors in acute leukemia[J].Leukemia,2000,14(3):505-508.
  • 5Saitoh M, Taguchi K, Momose K,et al.Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing lewis lung carcinoma cells[J].Cancer Chemother Pharmacol,2002,49(2):161-166.
  • 6Reynolds CH.Clinical efficacy of rhIL-11[J].Oncology(Huntingt),2000,14(9 Suppl 8):32-40.
  • 7Bussel JB,Mukherjee R,Stone AJ.A pilot study of rhIL-11 treatment of refractory ITP[J].Am J Hematol,2001,66(3):172-177.
  • 8John W,Smith H.Tolerability and side-effect profile of rhIL-11[J].Oncology,2000,14(9):41-47.
  • 9苏丽萍,郝国平,罗鹏飞,乔振华.慢性特发性血小板减少性紫癜患者细胞免疫功能的研究[J].中华血液学杂志,2000,21(3):144-145. 被引量:35

共引文献102

同被引文献9

  • 1张华,陶晓明,邓燕艺,李虎生.重组人白介素-11联合肾上腺皮质激素治疗特发性血小板减少性紫癜的临床观察[J].临床血液学杂志,2005,18(3):138-139. 被引量:13
  • 2吕学文,刘仿,伍昌林,肖红.急性ITP患儿外周血CD4^+ CD25^+ T细胞及相关细胞因子的研究[J].临床检验杂志,2007,25(2):104-106. 被引量:9
  • 3薛俭成,伍昌林,朱奕,李岚,张琼丽,党鑫堂.急性ITP患儿外周血调节性T细胞及相关细胞因子的研究[J].中国小儿血液与肿瘤杂志,2007,12(2):56-59. 被引量:3
  • 4VRHOVAC R. DELMER A. TANG R, et al. Prog-nostic significance of the cycle inhabition p27kiplinchronic leukemia [ J]. Blood, 1998,91:4694.
  • 5Frascal D, Cuid F, Arbitrio M, et al. Use of hematopoietic Cytokines the immune system in irradiated mice [ J ]. Exp Hematol, 1997,25 : 1167.
  • 6Chang M, Suen Y. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production [ J ]. Blood, 1996, 88 (9) :3354.
  • 7Fortunel N, Hatzfeld J, Kisselev S, et al. Release from quiescence of primitive human hematopoietic stem/ progenitor cellsby blocking their cell-surface TGF-beta type Ⅱ receptor in a short-term in vitro assay: Stem Cells, 2000,18 (2) : 102.
  • 8Blobe G C, Schieman W P, Lodish H F, et al. Role of transforming growth factor-β in human disease [ J ]. N Engl J Med, 2000, 342(18) : 1350.
  • 9Jirillo E,Amati L, Suppressa P, et al. Involvementof the transforming growth factor beta in the pa-thogenesis of hereditary hemorrhagic telangiectasia [ J]. Cuurr Pharm Des,2006,12 ( 10 ) : 1195.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部